1. CTIM-25. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT. (14th November 2022) Authors: Ricardo McFaline-Figueroa, J; Prins, Robert; Qiao, Yu; Sun, Lu; Li, Gang; Kim, Jiyoon; Lee, Eudocia; Nayak, Lakshmi; Chukwueke, Ugonma; Beroukhim, Rameen; Batchelor, Tracy; Chiocca, E Antonio; Doherty, Lisa; Stefanik, Jennifer; Partridge, Kathryn; Spearman, Amanda; Lavallee, Maria; Myers, Alexa; ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-18. PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723). (14th November 2022) Authors: Iwamoto, Fabio; Tanguturi, Shyam; Desai, Arati; Nayak, Lakshmi; Uhlmann, Erik; Wang, Tony; Lustig, Robert; Hertan, Lauren; Bagley, Stephen; Hayden, Julia; Laforest-Roys, Corey; Muzikansky, Alona; McCluskey, Christine; Chukwueke, Ugonma; McFaline-Figueroa, J Ricardo; Lee, Eudocia; Wen, Patrick Y; ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗